Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
For joints specifically, it is a repair assist, not a cure for arthritis
Skipping treatments or altering medication doses can reduce effectiveness and delay recovery
While Phase II trials in heart failure and primary mitochondrial myopathy did not meet primary efficacy endpoints, the TAZPOWER trial in Barth syndrome demonstrated significant improvements in muscle strength and sixminute walk distance, leading to FDA accelerated approval in 2025 [3] [10]
It might take longer to see full results
US$ 20.55
US$ 21.92
US$ 29.54
